Published in AIDS on January 01, 1998
Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin Microbiol Rev (2001) 2.87
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal. Clin Infect Dis (2009) 1.86
New insights into human cryptosporidiosis. Clin Microbiol Rev (1999) 1.72
Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients. Clin Exp Immunol (2001) 1.67
Early clinical manifestations associated with death from visceral leishmaniasis. PLoS Negl Trop Dis (2012) 1.18
A genetic mechanism for deletion of the ser2 gene cluster and formation of rough morphological variants of Mycobacterium avium. J Bacteriol (2000) 1.05
Ethambutol optimal clinical dose and susceptibility breakpoint identification by use of a novel pharmacokinetic-pharmacodynamic model of disseminated intracellular Mycobacterium avium. Antimicrob Agents Chemother (2010) 1.04
Analysis of a population-based Pneumocystis carinii pneumonia index as an outcome measure of access and quality of care for the treatment of HIV disease. Am J Public Health (2002) 1.04
Moxifloxacin pharmacokinetics/pharmacodynamics and optimal dose and susceptibility breakpoint identification for treatment of disseminated Mycobacterium avium infection. Antimicrob Agents Chemother (2010) 1.01
Up-regulation of TLR2 and TLR4 in dendritic cells in response to HIV type 1 and coinfection with opportunistic pathogens. AIDS Res Hum Retroviruses (2011) 0.95
Physiological correlates of HIV-related fatigue. Clin Nurs Res (2008) 0.93
Human immunodeficiency virus type 1 protease inhibitors block toll-like receptor 2 (TLR2)- and TLR4-Induced NF-kappaB activation. Antimicrob Agents Chemother (2004) 0.91
Modafinil treatment for fatigue in HIV/AIDS: a randomized placebo-controlled study. J Clin Psychiatry (2010) 0.90
Prognostic factors of survival of HIV-infected patients with cytomegalovirus disease: Aquitaine Cohort, 1986-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA). Eur J Epidemiol (2000) 0.83
The effect of opportunistic illness on HIV RNA viral load and CD4+ T cell count among HIV-positive adults taking antiretroviral therapy. J Int AIDS Soc (2013) 0.81
Infection of human cytomegalovirus in cultured human gingival tissue. Virol J (2006) 0.80
Interleukin-12-secreting fibroblasts are more efficient than free recombinant interleukin-12 in inducing the persistent resistance to Mycobacterium avium complex infection. Immunology (1999) 0.79
Induction of in vivo resistance to Mycobacterium avium infection by intramuscular injection with DNA encoding interleukin-18. Immunology (2001) 0.79
Effects of glycyrrhizin, an active component of licorice roots, on Candida albicans infection in thermally injured mice. Clin Exp Immunol (1999) 0.78
Human immunodeficiency virus type 1 Tat binds to Candida albicans, inducing hyphae but augmenting phagocytosis in vitro. Immunology (2001) 0.77
Disparities in the Magnitude of Human Immunodeficiency Virus-related Opportunistic Infections Between High and Low/Middle-income Countries: Is Highly Active Antiretroviral Therapy Changing the Trend? Ann Med Health Sci Res (2016) 0.75
Oesophageal candiasis in AIDS. Indian J Otolaryngol Head Neck Surg (2003) 0.75
A Study of Parasitic and Bacterial Pathogens Associated with Diarrhea in HIV-Positive Patients. Cureus (2016) 0.75
Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med (1995) 13.59
Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis (1987) 5.63
Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med (1999) 5.05
Self-reported antiretroviral therapy in injection drug users. JAMA (1998) 4.75
Clostridium difficile colitis: an efficient clinical approach to diagnosis. Ann Intern Med (1995) 4.42
Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. J Acquir Immune Defic Syndr (2001) 3.67
Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. J Infect Dis (1992) 3.61
Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS (2001) 3.56
Race, sex, drug use, and progression of human immunodeficiency virus disease. N Engl J Med (1995) 3.44
Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia. Blood (1992) 3.09
Net costs from three perspectives of using low versus high osmolality contrast medium in diagnostic angiocardiography. J Am Coll Cardiol (1993) 2.72
Knowledge, attitudes, and reported practices of medical students and house staff regarding the diagnosis and treatment of alcoholism. JAMA (1989) 2.56
Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia. Am J Med (1984) 2.54
Potential factors affecting adherence with HIV therapy. AIDS (1997) 2.44
The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia. J Infect Dis (1984) 2.44
Characteristics, diagnosis, and treatment of alcoholism in elderly patients. J Am Geriatr Soc (1989) 2.43
Anemia and survival in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 2.29
Association of initial CD4 cell count and viral load with response to highly active antiretroviral therapy. JAMA (2000) 2.25
Moderate alcohol consumption and coronary artery disease. A review. Medicine (Baltimore) (1986) 2.22
A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users. Am J Med (2001) 2.15
Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group. JAMA (1991) 2.08
Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus. Clin Infect Dis (1995) 2.01
31P NMR studies of intracellular free Mg2+ in intact frog skeletal muscle. J Biol Chem (1980) 2.01
NMR studies of intracellular metal ions in intact cells and tissues. Annu Rev Biophys Bioeng (1984) 1.97
Cryptosporidiosis in patients with AIDS: correlates of disease and survival. Clin Infect Dis (1998) 1.97
Comorbidities among HIV-infected injection drug users in Chennai, India. Indian J Med Res (2008) 1.95
Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Medicine (Baltimore) (1996) 1.90
Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.89
Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy. AIDS (2001) 1.88
Prophylaxis for opportunistic infections in patients with HIV infection. Ann Intern Med (1994) 1.87
Hazardous drinking is associated with an elevated aspartate aminotransferase to platelet ratio index in an urban HIV-infected clinical cohort. HIV Med (2008) 1.74
Alcohol abuse: comparison of two methods for assessing its prevalence and associated morbidity in hospitalized patients. Am J Med (1991) 1.66
Predictors of outpatient treatment retention: patient versus substance use characteristics. Drug Alcohol Depend (2001) 1.60
Neutropenia and bacterial infection in acquired immunodeficiency syndrome. Arch Intern Med (1995) 1.60
HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy. AIDS (2001) 1.60
The effect of adjunctive corticosteroids for the treatment of Pneumocystis carinii pneumonia on mortality and subsequent complications. Chest (1998) 1.58
Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients. J Infect Dis (1996) 1.58
Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med (1984) 1.57
Implications for macrolide treatment in community-acquired pneumonia. Hopkins CAP Team. Chest (1998) 1.57
The impact of prophylaxis on outcome and resource utilization in Pneumocystis carinii pneumonia. Chest (1995) 1.53
Risk factors for the development of auditory toxicity in patients receiving aminoglycosides. J Infect Dis (1984) 1.52
Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients. HIV Med (2005) 1.49
Prevention of opportunistic infections in the era of improved antiretroviral therapy. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.46
Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis (1998) 1.45
Lack of association between acyclovir use and survival in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group. J Infect Dis (1995) 1.45
Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography. N Engl J Med (1992) 1.40
The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults. J Infect Dis (1998) 1.40
Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology. Clin Infect Dis (1997) 1.38
Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. Am Rev Respir Dis (1992) 1.38
Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2001) 1.36
Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients with advanced HIV infection. Am J Respir Crit Care Med (2000) 1.35
Costs of HIV medical care in the era of highly active antiretroviral therapy. AIDS (1999) 1.33
Design of the multicenter study of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea. Control Clin Trials (1995) 1.32
Delayed hatching of salamander eggs in response to enhanced larval predation risk. Am Nat (1993) 1.31
Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea. AIDS (2000) 1.30
Community-acquired pneumonia: impact of immune status. Am J Respir Crit Care Med (1995) 1.29
Stimulation of Na:H exchange by insulin. Biophys J (1981) 1.28
Bacteroides fragilis toxin exhibits polar activity on monolayers of human intestinal epithelial cells (T84 cells) in vitro. Infect Immun (1997) 1.26
Effects of insulin upon ion transport. Biochim Biophys Acta (1983) 1.25
Hepatomegaly and steatosis in HIV-infected patients receiving nucleoside analog antiretroviral therapy. Am J Gastroenterol (1995) 1.24
Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution. J Infect Dis (2001) 1.19
Emergency department utilization among HIV-infected patients in a multisite multistate study. HIV Med (2009) 1.15
Disulfiram treatment of alcoholism. Am J Med (1990) 1.15
Social integration and black intraracial variation in blood pressure. Ethn Dis (1991) 1.15
Lessons learned from the design and implementation of myocardial infarction adjudication tailored for HIV clinical cohorts. Am J Epidemiol (2014) 1.14
A clinicopathologic analysis of AIDS-related cryptosporidiosis. AIDS (1998) 1.14
Intracellular pH mediates action of insulin on glycolysis in frog skeletal muscle. Am J Physiol (1982) 1.13
Effect of insulin upon the sodium pump in frog skeletal muscle. J Physiol (1973) 1.13
Effects of an incentive and education program on return rates for PPD test reading in patients with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.11
Incidence of pancreatitis in HIV-infected patients receiving nucleoside reverse transcriptase inhibitor drugs. AIDS (2001) 1.09
Cryptosporidiosis in northeastern Brazilian children: association with increased diarrhea morbidity. J Infect Dis (1998) 1.09
Physician tolerance for uncertainty. Use of liver-spleen scans to detect metastases. JAMA (1985) 1.08
Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent. Crit Care Med (1999) 1.07
Effect of insulin upon membrane-bound (Na+ + K+)-ATPase extracted from frog skeletal muscle. J Physiol (1975) 1.07
The incidence of and risk factors for MRSA bacteraemia in an HIV-infected cohort in the HAART era. HIV Med (2008) 1.03
Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine. AIDS (2000) 1.03
A model for predicting nephrotoxicity in patients treated with aminoglycosides. J Infect Dis (1986) 1.01
Functional status of persons with HIV infection in an ambulatory setting. J Acquir Immune Defic Syndr (1994) 1.00
Substance abuse-related admissions to adult intensive care. Chest (1993) 1.00
Body shape and composition in HIV-infected women: an urban cohort. HIV Med (2005) 1.00
Elevation of intracellular pH by insulin in frog skeletal muscle. Biochem Biophys Res Commun (1979) 0.97
Nonlinear modeling of alcohol consumption for analysis of beverage type effects and beverage preference effects. Am J Epidemiol (1992) 0.97
Restimulation of antibody synthesis by antigen in cultures of lymphocytes. Nature (1968) 0.96
Letter: Personnel monitoring in diagnostic radiology. Br J Radiol (1973) 0.96
Risk factors for pneumococcal disease in human immunodeficiency virus-infected patients. J Infect Dis (1996) 0.96
Synthesis of antibody by lymphocytes restimulated in vitro with antigen. J Reticuloendothel Soc (1971) 0.95
Transplantation of autoimmune potential. II. Glomerulonephritis in lethally irradiated DBA/2 recipients of NZB bone marrow cells. Transplantation (1975) 0.94